Publication

Seroprevalence screening for the West Nile virus in Malaysia's Orang Asli population

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Suria Marlina, University MalayaSiti Fatimah Muhd Radzi, University MalayaRafidah Lani, University MalayaKhor Chee Sieng, University MalayaNurul Farhana Abdul Rahim, University MalayaHabibi Hassan, University MalayaLi-Yen Chang, University MalayaSazaly AbuBakar, University MalayaKeivan Zandi, Emory University
Language
  • English
Date
  • 2014-12-17
Publisher
  • BioMed Central
Publication Version
Copyright Statement
  • © 2014 Marlina et al.; licensee BioMed Central.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1756-3305
Volume
  • 7
Issue
  • 1
Start Page
  • 597
End Page
  • 597
Grant/Funding Information
  • The authors thank the University Malaya Research Grant (UMRG) RP013-2012C, High Impact Research (HIR) grant E000087-20001, Naval Medical Research Center - Asia and the Department of State, Biosecurity Engagement Program (NAMRU: J-55025-75053) and the University of Malaya (Flagship: FL001-13HTM) for funding the expenses of this study and also the staff and researchers in Tropical Infectious Disease Research Centre, Department of Medical Microbiology, Faculty of Medicine, University of Malaya for their dependable uphill struggle and support throughout the study.
Abstract
  • Background: West Nile virus (WNV) infection is an emerging zoonotic disease caused by an RNA virus of the genus Flavivirus. WNV is preserved in the environment through cyclic transmission, with mosquitoes, particularly Culex species, serving as a vector, birds as an amplifying host and humans and other mammals as dead-end hosts. To date, no studies have been carried out to determine the prevalence of the WNV antibody in Malaysia. The aim of this study was to screen for the seroprevalence of the WNV in Malaysia's Orang Asli population. Methods: Serum samples of 742 Orang Asli were collected in seven states in peninsular Malaysia. The samples were assessed to determine the seroprevalence of WNV immunoglobulin (Ig)G with the WNV IgG enzyme-linked immunosorbent assay (ELISA) method. For each individual, we documented the demographic factors. Anti-dengue and anti-tick-borne encephalitis virus IgG ELISA were also performed to rule out a cross reaction. All statistical analyses were performed using the GraphPad Prism 6 (GraphPad Software, Inc.); p values of less than 0.05 were considered significant. Results: The serosurvey included 298 men (40.16%) and 444 women (59.84%) of Malaysia's Orang Asli. Anti-WNV IgG was found in 9 of the 742 samples (1.21%). The seroprevalence was 0.67% (2 of 298) in men and 1.58% (7 of 444) in women. The presence of anti-WNV IgG was found not to be associated with gender but, however, did correlate with age. The peak seroprevalence was found to be 2.06% (2 of 97) in individuals between 30 to 42 years of age. Conclusions: No previous studies have examined the seroprevalence of the WNV antibody in the human population in Malaysia, and no clinical reports of infections have been made. Screening for the WNV seroprevalence is very significant because of many risk factors contribute to the presence of WNV in Malaysia, such as the abundance of Culex mosquitoes as the main vector and a high degree of biodiversity, including migratory birds that serve as a reservoir to the virus.
Author Notes
  • Correspondence: keivan@um.edu.my. Tropical Infectious Disease Research and Education Center (TIDREC), Department of Medical Microbiology, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia
Keywords
Research Categories
  • Health Sciences, Epidemiology
  • Biology, Microbiology

Tools

Relations

In Collection:

Items